Thierry Lambert

10.2k total citations
169 papers, 7.4k citations indexed

About

Thierry Lambert is a scholar working on Hematology, Molecular Medicine and Molecular Biology. According to data from OpenAlex, Thierry Lambert has authored 169 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Hematology, 49 papers in Molecular Medicine and 39 papers in Molecular Biology. Recurrent topics in Thierry Lambert's work include Hemophilia Treatment and Research (68 papers), Antibiotic Resistance in Bacteria (49 papers) and Blood Coagulation and Thrombosis Mechanisms (28 papers). Thierry Lambert is often cited by papers focused on Hemophilia Treatment and Research (68 papers), Antibiotic Resistance in Bacteria (49 papers) and Blood Coagulation and Thrombosis Mechanisms (28 papers). Thierry Lambert collaborates with scholars based in France, Italy and United States. Thierry Lambert's co-authors include Patrice Courvalin, Sophie Magnet, Marc Galimand, G Gerbaud, Laurence Damier-Piolle, Marie-Cécile Ploy, Patrice Nordmann, Sylvie Brémont, Laurent Poirel and Isabelle Marchand and has published in prestigious journals such as The EMBO Journal, Blood and Hepatology.

In The Last Decade

Thierry Lambert

163 papers receiving 7.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Lambert France 45 4.0k 2.1k 1.9k 1.8k 1.0k 169 7.4k
Göran Kronvall Sweden 39 1.0k 0.3× 1.7k 0.8× 556 0.3× 223 0.1× 341 0.3× 125 5.1k
Satoshi Ichiyama Japan 39 1.7k 0.4× 1.0k 0.5× 960 0.5× 120 0.1× 376 0.4× 217 5.8k
Reuben Ramphal United States 56 1.9k 0.5× 3.5k 1.6× 1.3k 0.7× 112 0.1× 129 0.1× 134 8.6k
Michael A. Bachman United States 27 1.6k 0.4× 1.2k 0.6× 1.0k 0.5× 132 0.1× 139 0.1× 53 3.5k
Tyrone L. Pitt United Kingdom 41 3.7k 0.9× 3.0k 1.4× 1.9k 1.0× 49 0.0× 425 0.4× 145 7.3k
Yunsong Yu China 46 5.6k 1.4× 2.3k 1.1× 2.3k 1.2× 46 0.0× 1.3k 1.3× 379 8.0k
K. J. Towner United Kingdom 35 4.1k 1.0× 2.1k 1.0× 2.3k 1.2× 39 0.0× 701 0.7× 109 6.0k
Mitsuo Kaku Japan 40 900 0.2× 1.3k 0.6× 445 0.2× 263 0.1× 120 0.1× 333 5.7k
Seok Hoon Jeong South Korea 45 4.5k 1.1× 1.6k 0.8× 2.2k 1.1× 39 0.0× 1000 1.0× 293 6.9k
Donald E. Woods Canada 56 1.2k 0.3× 3.0k 1.4× 1.2k 0.7× 93 0.1× 204 0.2× 151 8.9k

Countries citing papers authored by Thierry Lambert

Since Specialization
Citations

This map shows the geographic impact of Thierry Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Lambert more than expected).

Fields of papers citing papers by Thierry Lambert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Lambert. The network helps show where Thierry Lambert may publish in the future.

Co-authorship network of co-authors of Thierry Lambert

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Lambert. A scholar is included among the top collaborators of Thierry Lambert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Lambert. Thierry Lambert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tardy, Brigitte, Thierry Lambert, Marc Trossaërt, et al.. (2022). Revised terminal half‐life of nonacog alfa as derived from extended sampling data: A real‐world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis. Haemophilia. 28(4). 542–547. 4 indexed citations
3.
Steichen, Clara, M Allouche, Antonietta Messina, et al.. (2021). In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model. Hepatology. 75(4). 866–880. 14 indexed citations
4.
Khayat, Claudia Djambas, M. El Khorassani, Thierry Lambert, et al.. (2019). Clinical pharmacology, efficacy and safety study of a triple‐secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiency. Journal of Thrombosis and Haemostasis. 17(4). 635–644. 24 indexed citations
5.
Lambert, Thierry. (2018). Résistances a l'impót. Attachement a l'État. Enquete sur les contribuables français. 581–581. 3 indexed citations
6.
Lambert, Thierry, et al.. (2018). PSY223 - QUALITATIVE RESEARCH IN HAEMOPHILIA A: EMICIZUMAB TRANSFORMS LIFESTYLE OF PATIENTS WITH INHIBITOR. Value in Health. 21. S474–S474. 1 indexed citations
7.
Dolan, G., Gary Benson, Anne Duffy, et al.. (2017). Haemophilia B: Where are we now and what does the future hold?. Blood Reviews. 32(1). 52–60. 37 indexed citations
8.
Candela, Thomas, Jean‐Christophe Marvaud, Tiep Khac Nguyen, & Thierry Lambert. (2017). A cfr- like gene cfr (C) conferring linezolid resistance is common in Clostridium difficile. International Journal of Antimicrobial Agents. 50(3). 496–500. 42 indexed citations
9.
Chambost, Hérvè, Christoph Male, Thierry Lambert, et al.. (2016). Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Thrombosis and Haemostasis. 116(10). 659–668. 46 indexed citations
10.
Thès, André, et al.. (2015). Simultaneous bilateral total knee arthroplasty in severe hemophilia: A retrospective cost-effectiveness analysis. Orthopaedics & Traumatology Surgery & Research. 101(2). 147–150. 9 indexed citations
11.
Touchon, Marie, Jean Cury, Eun-Jeong Yoon, et al.. (2014). The Genomic Diversification of the Whole Acinetobacter Genus: Origins, Mechanisms, and Consequences. Genome Biology and Evolution. 6(10). 2866–2882. 212 indexed citations
12.
Sørensen, Benny, Günter Auerswald, Gary Benson, et al.. (2014). Rationale for individualizing haemophilia care. Blood Coagulation & Fibrinolysis. 26(8). 849–857. 17 indexed citations
13.
Fusco, Francesca, L Scalone, Angiola Rocino, et al.. (2011). Cost of Immune Tolerance Induction in Hemophilia A Patients: Results from the ITER Study. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 2005(26). nf52–nf52. 1 indexed citations
14.
Wolf, P. E., Laurent Guyon, Thierry Lambert, et al.. (2009). Probing helium interfaces with light scattering: From fluid mechanics to statistical physics. The European Physical Journal E. 28(2). 183–198. 9 indexed citations
15.
Guessennd, Nathalie, Sylvie Brémont, Euloge Ekaza, et al.. (2008). Résistance aux quinolones de type qnr chez les entérobactéries productrices de bêta-lactamases à spectre élargi à Abidjan en Côte d’Ivoire. Pathologie Biologie. 56(7-8). 439–446. 48 indexed citations
16.
Santagostino, Elena, A. Faradji, Alfonso Iorio, et al.. (2007). Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting. Thrombosis and Haemostasis. 99(1). 52–58. 35 indexed citations
17.
Bouttier, Sylvie, et al.. (2004). The gene of confers multidrug resistance in. FEMS Microbiology Letters. 238(1). 93–100. 16 indexed citations
18.
d’Oiron, Roseline, J. M. Lavergne, J Peynet, et al.. (2003). Response to DDAVP in mild/moderate haemophilia A patients according to the underlying Factor VIII genotype. Journal of Thrombosis and Haemostasis. 1. 4 indexed citations
19.
Lambert, Thierry, et al.. (1995). Les politiques fiscales sous la Cinquième République : discours et pratiques (1958-1991). L'Harmattan eBooks. 1 indexed citations
20.
Yandza, T., Thierry Lambert, Fernando Álvarez, et al.. (1994). OUTCOME OF ABO-INCOMPATIBLE LIVER TRANSPLANTATION IN CHILDREN WITH NO SPECIFIC ALLOANTIBODIES AT THE TIME OF TRANSPLANTATION1. Transplantation. 58(1). 46–50. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026